Skip to main content
. 2023 May 12;16:1128545. doi: 10.3389/fnmol.2023.1128545

Figure 1.

Figure 1

Spinal cord cross-sections of one NK1 receptor antagonist (NRA) and one vehicle animal at 10 × and 40 × magnification stained for SP (A, red) and NK-1R (B, yellow). (C) Mean immunointensity of SP in the spinal cord 7 days after SCI/sham surgery. (D) Mean cell density (cells/mm2) of DAPI+&NK-1R+ cells in the spinal cord 7 days after SCI/sham surgery (Orange cross, microvessel in the spinal cord) (n = 6/group; one-way repeated measures ANOVA followed by post-hoc Tukey-HSD-test; ***p < 0.001; *p < 0.05).